Svoronos Dawn is a director of Xenon Pharmaceuticals Inc.
Person profile
Roles
Address
San Francisco, California
Employees
Former names
Graham Dawn
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Xenon Pharmaceuticals Inc.
24 Aug 23
144
Xenon Pharmaceuticals Inc.
24 Aug 23
4
Adverum Biotechnologies, Inc.
13 Jun 23
4
Xenon Pharmaceuticals Inc.
2 Jun 23
4
ACELYRIN, Inc.
11 May 23
4
ACELYRIN, Inc.
4 May 23
3
ACELYRIN, Inc.
4 May 23
4
Global Blood Therapeutics, Inc.
6 Oct 22
4
Xenon Pharmaceuticals Inc.
29 Jun 22
4
Global Blood Therapeutics, Inc.
22 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Aug 23 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 38.7 | 25,000 | 967.50 k | 25,000 |
9 Jun 23 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 1.56 | 40,000 | 62.40 k | 40,000 |
2 Jun 23 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 38.96 | 18,475 | 719.79 k | 18,475 |
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | No | No | 18 | 15,000 | 270.00 k | 15,000 |
9 May 23 | SLRN Acelyrin | Director Stock Option Common Stock | Other | Acquire J | No | No | 18 | 23,243 | 418.37 k | 23,243 |
9 May 23 | SLRN Acelyrin | Director Stock Option Class A Common Stock | Other | Dispose J | No | No | 18 | 23,243 | 418.37 k | 0 |
9 May 23 | SLRN Acelyrin | Director Stock Option Common Stock | Other | Acquire J | No | No | 5.8766 | 155,450 | 913.52 k | 155,450 |
9 May 23 | SLRN Acelyrin | Director Stock Option Class A Common Stock | Other | Dispose J | No | No | 5.8766 | 155,450 | 913.52 k | 0 |